We are live on ! Find out more
JNCE

Jounce Therapeutics, Inc. Common Stock
JNCE

Delisted

JNCE was delisted on the 3rd of May, 2023.

Back to rankings

1 hedge funds and large institutions have $918K invested in Jounce Therapeutics, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 83 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less capital invested

Capital invested by funds: $64.1M → $918K (-$63.1M)

99% less funds holding

Funds holding: 84 → 1 (-83)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 83

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
1
Holders Change
-83
Holders Change %
-98.81%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
83
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
TCM
Tang Capital Management
California
-$9.81M
2
DTC
Deep Track Capital
Connecticut
-$7.88M
3
Tudor Investment Corp
Tudor Investment Corp
Connecticut
-$5.85M
4
BlackRock
BlackRock
New York
-$4.71M
5
OM
Opaleye Management
Massachusetts
-$4.21M
Name Holding Trade Value Shares
Change 		Change in
Stake
CG
51
Colony Group
Massachusetts
– -$46K -25,000 Closed
CL
52
CSS LLC
Illinois
– -$46.3K -25,000 Closed
Franklin Resources
53
Franklin Resources
California
– -$44.8K -24,226 Closed
Barclays
54
Barclays
United Kingdom
– -$39.8K -21,498 Closed
FT
55
Fiduciary Trust
Massachusetts
– -$39.2K -21,185 Closed
UBS Group
56
UBS Group
Switzerland
– -$38.9K -21,031 Closed
AIG
57
American International Group
New York
– -$37.6K -20,337 Closed
VOYA Investment Management
58
VOYA Investment Management
Georgia
– -$33.8K -18,274 Closed
California State Teachers Retirement System (CalSTRS)
59
California State Teachers Retirement System (CalSTRS)
California
– -$29K -15,666 Closed
Commonwealth Equity Services
60
Commonwealth Equity Services
Massachusetts
– -$28 -15,572 Closed
New York State Common Retirement Fund
61
New York State Common Retirement Fund
New York
– -$28.6K -15,468 Closed
Connor, Clark & Lunn Investment Management (CC&L)
62
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
– -$28.5K -15,404 Closed
SG Americas Securities
63
SG Americas Securities
New York
– -$28K -15,195 Closed
FIA
64
FNY Investment Advisers
New York
– -$27K -15,000 Closed
CAPTRUST Financial Advisors
65
CAPTRUST Financial Advisors
North Carolina
– -$27.1K -14,660 Closed
KAM
66
Knightsbridge Asset Management
California
– -$25K -13,542 Closed
AA
67
Advisory Alpha
Michigan
– -$22.2K -12,005 Closed
HFS
68
Horizon Financial Services
North Carolina
– -$22.2K -12,005 Closed
LPL Financial
69
LPL Financial
California
– -$19.9K -10,740 Closed
Fidelity Investments
70
Fidelity Investments
Massachusetts
– -$18.9K -10,207 Closed
BRA
71
Bender Robert & Associates
California
– -$18.5K -10,000 Closed
MML Investors Services
72
MML Investors Services
Massachusetts
– -$18K -10,000 Closed
Wells Fargo
73
Wells Fargo
California
– -$14.4K -7,784 Closed
TRCT
74
Tower Research Capital (TRC)
New York
– -$10K -5,519 Closed
SO
75
STRS Ohio
Ohio
– -$7K -4,100 Closed
1 2
3
4

JNCE Hedge Fund Activity: Q2 2023 in Review

1 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Jounce Therapeutics, Inc. Common Stock (JNCE) for Q2 2023, worth a combined $918K — down 99% from $64.1M a quarter earlier.

Sellers outnumbered buyers: 83 funds closed out of JNCE and 0 opened new positions — a net loss of 83 holders — while 1 trimmed existing stakes and 0 added.

The largest seller was Tang Capital Management, exiting entirely with an estimated $9.81M sold.

  • 1 institutional investor held Jounce Therapeutics, Inc. Common Stock (JNCE) as of Q2 2023, down from 84 in Q1 2023.
  • Funds reported $918K of Jounce Therapeutics, Inc. Common Stock stock for Q2 2023, down 99% quarter-over-quarter.
  • 0 funds opened new Jounce Therapeutics, Inc. Common Stock positions in Q2 2023 and 83 closed out, a net change of -83 holders.
  • The largest Jounce Therapeutics, Inc. Common Stock seller in Q2 2023 was Tang Capital Management, an estimated $9.81M sold.

Based on aggregated 13F filings for Q2 2023.